Dean W. Hum

Affiliations: 
Universite Laval (Canada) 
Area:
Animal Physiology Biology, Molecular Biology
Google:
"Dean Hum"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hanf R, Millatt LJ, Cariou B, et al. (2014) The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects. Diabetes & Vascular Disease Research. 11: 440-7
Staels B, Rubenstrunk A, Noel B, et al. (2013) Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.). 58: 1941-52
Lauressergues E, Bert E, Duriez P, et al. (2012) Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? Neuropharmacology. 62: 784-796
Lauressergues E, Martin F, Helleboid A, et al. (2011) Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver Naunyn-Schmiedebergs Archives of Pharmacology. 383: 423-436
Lauressergues E, Staels B, Valeille K, et al. (2010) Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes Naunyn-Schmiedebergs Archives of Pharmacology. 381: 427-439
Gineste R, Sirvent A, Paumelle R, et al. (2008) Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity Molecular Endocrinology. 22: 2433-2447
Gizard F, Robillard R, Gross B, et al. (2006) TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Molecular and Cellular Biology. 26: 7632-44
Gizard F, Robillard R, Barbier O, et al. (2005) TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1. Molecular and Cellular Biology. 25: 4335-48
Genoux A, Dehondt H, Helleboid-Chapman A, et al. (2005) Transcriptional Regulation of Apolipoprotein A5 Gene Expression by the Nuclear Receptor RORα Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1186-1192
Sirvent A, Verhoeven AJM, Jansen H, et al. (2004) Farnesoid X receptor represses hepatic lipase gene expression. Journal of Lipid Research. 45: 2110-2115
See more...